4.7 Article

The Effect of CDK6 Expression on DNA Methylation and DNMT3B Regulation

Journal

ISCIENCE
Volume 23, Issue 10, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.isci.2020.101602

Keywords

-

Funding

  1. European Research Council (ERC) under the European Union [694354]
  2. Austrian Science Fund [P31773]
  3. European Research Council (ERC) [694354] Funding Source: European Research Council (ERC)
  4. Austrian Science Fund (FWF) [P31773] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

CDK6 is frequently overexpressed in various cancer types and functions as a positive regulator of the cell cycle and as a coregulator of gene transcription. We provide evidence that CDK6 is involved in the process of DNA methylation, at least in ALL. We observe a positive correlation of CDK6 and DNMT expression in a large number of ALL samples. ChIP-seq analysis reveals CDK6 binding to genomic regions associated with DNA methyltransferases (DNMTs). ATAC-seq shows a strong reduction in chromatin accessibility for DNMT3B in CDK6-deficient BCR-ABL(+) Cdk6(-/-) cells, accompanied by lower levels of DNMT3B mRNA and less chromatin-bound DNMT3B, as shown by RNA-seq and chromatome analysis. Motif analysis suggests that ETS family members interact with CDK6 to regulate DNMT3B. Reduced representation bisulfite sequencing analysis uncovers reversible and cell line-specific changes in DNA methylation patterns upon CDK6 loss. The results reveal a function of CDK6 as a regulator of DNA methylation in transformed cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available